Angiotensin-converting enzyme (ACE) polymorphisms, angiotensin II, ACE inhibitors and glomerulosclerosis--a hypothesis.
Roy-Chaudhury
P
P
Khan
I H
IH
D000804:Angiotensin II / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D004251:DNA Transposable Elements; D005838:Genotype; D005920:Glomerular Mesangium / Q000166:cytology / Q000187:drug effects* / Q000473:pathology; D005921:Glomerulonephritis / Q000453:epidemiology / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011110:Polymorphism, Genetic; D012307:Risk Factors; D017384:Sequence Deletion
D000806:Angiotensin-Converting Enzyme Inhibitors; D004251:DNA Transposable Elements; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A